Differential Roles of EPS8 in Carcinogenesis: Loss of Protein Expression in a Subset of Colorectal Carcinoma and Adenoma

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2012 Aug 10

PMID 22876043

Citations 6

Authors

Wael M Abdel-Rahman

Salla Ruosaari

Sakari Knuutila

Paivi Peltomaki

Affiliations

Soon will be listed here.

Abstract

Aim: To analyze the epidermal growth factor receptor pathway substrate 8 (EPS8) expression status and role in colorectal carcinogenesis given that EPS8 has a conserved actin barbed-end capping function that is required for proper maturation in intestinal cells.

Methods: We studied 8 colon cancer cell lines and 58 colorectal tumors (19 adenomas and 39 carcinomas). We performed expression microarray analysis of colon cancer cell lines followed by loss of heterozygosity (LOH) analysis and immunohistochemistry for EPS8 expression in colon tumors. Subsequently, we performed mutation analysis by direct sequencing and methylation analysis by bisulfite sequencing and methylation-specific polymerase chain reaction assays.

Results: Expression microarray analysis of colon cancer cell lines showed overexpression of EPS8 transcript in all lines but RKO. Genome wide loss of heterozygosity (LOH) analysis of colon tumors, showed considerable LOH at the EPS8 gene locus. Immunohistochemically, EPS8 was constitutively expressed in normal colonic mucosa with a dot-like supranuclear localization with accentuation at the luminal surface supporting its proposed role in epithelial maturation. Nineteen colon tumors (4 adenoma, 15 carcinoma) out of 51 (37%) showed strikingly tumor specific EPS8 protein loss. Of the remaining tumors, 5/51 (2 adenoma, and 3 carcinoma, 10%) showed marked overexpression, while 27/51 tumors (53%) showed retained expression. Mutation analysis revealed a missense mutation (c.794C>T, p.R265C) in exon 8 in RKO. The EPS8 promoter was also methylated in RKO, but there was no significant methylation in other cell lines or carcinoma specimens.

Conclusion: The loss of EPS8 expression in colorectal adenomas and carcinomas suggests that down regulation of this gene contributes to the development of a subset of colorectal cancers, a finding which could have applications in diagnosis and treatment.

Citing Articles

Loss of EPS8 sensitizes non-small-cell lung carcinoma to chemotherapy-induced DNA damage.

Qiu Y, Xu B, Feng J, Wang C, Chen Y, He Y Cancer Gene Ther. 2023; 30(7):997-1006.

PMID: 36932195 DOI: 10.1038/s41417-023-00606-1.

Calponin 3 promotes invasion and drug resistance of colon cancer cells.

Nair V, Al-Khayyal N, Sivaperumal S, Abdel-Rahman W World J Gastrointest Oncol. 2019; 11(11):971-982.

PMID: 31798778 PMC: 6883188. DOI: 10.4251/wjgo.v11.i11.971.

The Role of Chromosomal Instability and Epigenetics in Colorectal Cancers Lacking β-Catenin/TCF Regulated Transcription.

Abdel-Rahman W, Lotsari-Salomaa J, Kaur S, Niskakoski A, Knuutila S, Jarvinen H Gastroenterol Res Pract. 2016; 2016:6089658.

PMID: 27047543 PMC: 4800109. DOI: 10.1155/2016/6089658.

DNA Methylation Dynamics During Differentiation, Proliferation, and Tumorigenesis in the Intestinal Tract.

Huang C, Yu T, Chen Q Stem Cells Dev. 2015; 24(23):2733-9.

PMID: 26413818 PMC: 4653825. DOI: 10.1089/scd.2015.0235.

Construction and analysis of regulatory genetic networks in cervical cancer based on involved microRNAs, target genes, transcription factors and host genes.

Wang N, Xu Z, Wang K, Zhu M, Li Y Oncol Lett. 2014; 7(4):1279-1283.

PMID: 24944708 PMC: 3961274. DOI: 10.3892/ol.2014.1814.

References

Abdel-Rahman W, Katsura K, Rens W, GORMAN P, Sheer D, Bicknell D . Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement. Proc Natl Acad Sci U S A. 2001; 98(5):2538-43. PMC: 30173. DOI: 10.1073/pnas.041603298. View

Abdel-Rahman W, Kalinina J, Shoman S, Eissa S, Ollikainen M, Elomaa O . Somatic FGF9 mutations in colorectal and endometrial carcinomas associated with membranous beta-catenin. Hum Mutat. 2008; 29(3):390-7. DOI: 10.1002/humu.20653. View

Veigl M, Kasturi L, Olechnowicz J, Ma A, Lutterbaugh J, Periyasamy S . Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci U S A. 1998; 95(15):8698-702. PMC: 21139. DOI: 10.1073/pnas.95.15.8698. View

Renkonen E, Zhang Y, Lohi H, Salovaara R, Abdel-Rahman W, Nilbert M . Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer. J Clin Oncol. 2003; 21(19):3629-37. DOI: 10.1200/JCO.2003.03.181. View

DA COSTA L, He T, Yu J, Sparks A, Morin P, Polyak K . CDX2 is mutated in a colorectal cancer with normal APC/beta-catenin signaling. Oncogene. 1999; 18(35):5010-4. DOI: 10.1038/sj.onc.1202872. View

Chen Y, Shen M, Chen Y, Maa M, Leu T . Eps8 decreases chemosensitivity and affects survival of cervical cancer patients. Mol Cancer Ther. 2008; 7(6):1376-85. DOI: 10.1158/1535-7163.MCT-07-2388. View

Disanza A, Carlier M, Stradal T, Didry D, Frittoli E, Confalonieri S . Eps8 controls actin-based motility by capping the barbed ends of actin filaments. Nat Cell Biol. 2004; 6(12):1180-8. DOI: 10.1038/ncb1199. View

Innocenti M, Tenca P, Frittoli E, Faretta M, Tocchetti A, Di Fiore P . Mechanisms through which Sos-1 coordinates the activation of Ras and Rac. J Cell Biol. 2002; 156(1):125-36. PMC: 2173577. DOI: 10.1083/jcb.200108035. View

Scita G, Tenca P, Areces L, Tocchetti A, Frittoli E, Giardina G . An effector region in Eps8 is responsible for the activation of the Rac-specific GEF activity of Sos-1 and for the proper localization of the Rac-based actin-polymerizing machine. J Cell Biol. 2001; 154(5):1031-44. PMC: 2196181. DOI: 10.1083/jcb.200103146. View

10.

Scita G, Nordstrom J, Carbone R, Tenca P, Giardina G, Gutkind S . EPS8 and E3B1 transduce signals from Ras to Rac. Nature. 1999; 401(6750):290-3. DOI: 10.1038/45822. View

11.

Kuismanen S, Moisio A, Schweizer P, Truninger K, Salovaara R, Arola J . Endometrial and colorectal tumors from patients with hereditary nonpolyposis colon cancer display different patterns of microsatellite instability. Am J Pathol. 2002; 160(6):1953-8. PMC: 1850838. DOI: 10.1016/S0002-9440(10)61144-3. View

12.

Abdel-Rahman W, Lohi H, Knuutila S, Peltomaki P . Restoring mismatch repair does not stop the formation of reciprocal translocations in the colon cancer cell line HCA7 but further destabilizes chromosome number. Oncogene. 2004; 24(4):706-13. DOI: 10.1038/sj.onc.1208129. View

13.

Welsch T, Endlich K, Giese T, Buchler M, Schmidt J . Eps8 is increased in pancreatic cancer and required for dynamic actin-based cell protrusions and intercellular cytoskeletal organization. Cancer Lett. 2007; 255(2):205-18. DOI: 10.1016/j.canlet.2007.04.008. View

14.

Abdel-Rahman W, Ollikainen M, Kariola R, Jarvinen H, Mecklin J, Nystrom-Lahti M . Comprehensive characterization of HNPCC-related colorectal cancers reveals striking molecular features in families with no germline mismatch repair gene mutations. Oncogene. 2005; 24(9):1542-51. DOI: 10.1038/sj.onc.1208387. View

15.

Matoskova B, Wong W, Salcini A, Pelicci P, Di Fiore P . Constitutive phosphorylation of eps8 in tumor cell lines: relevance to malignant transformation. Mol Cell Biol. 1995; 15(7):3805-12. PMC: 230619. DOI: 10.1128/MCB.15.7.3805. View

16.

Wang H, Patel V, Miyazaki H, Gutkind J, Yeudall W . Role for EPS8 in squamous carcinogenesis. Carcinogenesis. 2008; 30(1):165-74. DOI: 10.1093/carcin/bgn252. View

17.

Revenu C, Athman R, Robine S, Louvard D . The co-workers of actin filaments: from cell structures to signals. Nat Rev Mol Cell Biol. 2004; 5(8):635-46. DOI: 10.1038/nrm1437. View

18.

Fazioli F, Minichiello L, Matoska V, Castagnino P, Miki T, Wong W . Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF-dependent mitogenic signals. EMBO J. 1993; 12(10):3799-808. PMC: 413663. DOI: 10.1002/j.1460-2075.1993.tb06058.x. View

19.

Maa M, Lee J, Chen Y, Chen Y, Lee Y, Wang S . Eps8 facilitates cellular growth and motility of colon cancer cells by increasing the expression and activity of focal adhesion kinase. J Biol Chem. 2007; 282(27):19399-409. DOI: 10.1074/jbc.M610280200. View

20.

Irizarry R, Bolstad B, Collin F, Cope L, Hobbs B, Speed T . Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003; 31(4):e15. PMC: 150247. DOI: 10.1093/nar/gng015. View